(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
2020-07-04
عنوان الدراسة
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
داعم الدراسة
Novartis
دواء الدراسة
Ultibro breezhaler
رقم بروتوكول الدراسة
A3405 V01
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。